O	O	O	0	3	The	The	B-NP	DT	O	6	NMOD	O
T13	B-Entity	B-Entity	4	12	carboxyl	carboxyl	I-NP	NN	B-protein	6	NMOD	B-protein
T13	I-Entity	I-Entity	12	13	-	-	O	HYPH	I-protein	6	P	I-protein
T13	I-Entity	I-Entity	13	21	terminal	terminal	B-NP	JJ	I-protein	6	NMOD	I-protein
T13	I-Entity	I-Entity	22	33	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	6	NMOD	I-protein
T13	I-Entity	I-Entity	34	40	domain	domain	I-NP	NN	I-protein	9	SUB	I-protein
O	O	O	41	43	of	of	B-PP	IN	O	6	NMOD	O
T1	B-Protein	B-Protein	44	48	CD36	CD36	B-NP	NN	B-protein	7	PMOD	B-protein
O	O	O	49	51	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	52	60	required	require	I-VP	VBN	O	9	VC	O
O	O	O	61	64	for	for	B-PP	IN	O	10	VMOD	O
O	O	O	65	73	oxidized	oxidize	B-NP	VBN	O	17	NMOD	O
O	O	O	74	77	low	low	I-NP	JJ	O	17	NMOD	O
O	O	O	77	78	-	-	I-NP	HYPH	O	17	NMOD	O
O	O	O	78	85	density	density	I-NP	NN	O	17	NMOD	O
O	O	O	86	97	lipoprotein	lipoprotein	I-NP	NN	O	17	NMOD	O
O	O	O	98	108	modulation	modulation	I-NP	NN	O	11	PMOD	O
O	O	O	109	111	of	of	B-PP	IN	O	17	NMOD	O
T14	B-Entity	B-Entity	112	114	NF	NF	B-NP	NN	B-protein	21	NMOD	B-protein
T14	I-Entity	I-Entity	114	115	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T14	I-Entity	I-Entity	115	121	kappaB	kappaB	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	O	122	130	activity	activity	I-NP	NN	O	18	PMOD	O
O	O	O	131	133	by	by	B-PP	IN	O	17	NMOD	O
T2	B-Protein	B-Protein	134	139	tumor	tumor	B-NP	NN	B-protein	28	NMOD	B-protein
T2	I-Protein	I-Protein	140	148	necrosis	necrosis	I-NP	NN	I-protein	28	NMOD	I-protein
T2	I-Protein	I-Protein	149	155	factor	factor	I-NP	NN	I-protein	28	NMOD	I-protein
T2	I-Protein	I-Protein	155	156	-	-	B-VP	HYPH	I-protein	28	P	I-protein
T2	I-Protein	I-Protein	156	161	alpha	alpha	B-NP	SYM	I-protein	23	PMOD	I-protein
O	O	O	161	162	.	.	O	.	O	9	P	O

O	O	O	164	167	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	168	175	binding	binding	I-NP	NN	O	17	SUB	O
O	O	O	176	178	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	179	187	oxidized	oxidize	B-NP	VBN	O	8	NMOD	O
O	O	O	188	191	low	low	I-NP	JJ	O	8	NMOD	O
O	O	O	191	192	-	-	I-NP	HYPH	O	8	NMOD	O
O	O	O	192	199	density	density	I-NP	NN	O	8	NMOD	O
O	O	O	200	211	lipoprotein	lipoprotein	I-NP	NN	O	3	PMOD	O
O	O	O	212	213	(	(	O	(	O	12	DEP	O
O	O	O	213	215	Ox	Ox	B-NP	NN	O	11	NMOD	O
O	O	O	216	219	LDL	LDL	I-NP	NN	O	12	DEP	O
O	O	O	219	220	)	)	O	)	O	8	NMOD	O
O	O	O	221	223	by	by	B-PP	IN	O	2	NMOD	O
O	O	O	224	232	monocyte	monocyte	B-NP	NN	B-cell_type	16	NMOD	B-cell_type
O	O	O	232	233	-	-	O	HYPH	O	16	NMOD	O
O	O	O	233	244	macrophages	macrophage	B-NP	NNS	B-cell_type	13	PMOD	B-cell_type
O	O	O	245	251	causes	cause	B-VP	VBZ	O	0	ROOT	O
O	O	O	252	263	pleiotropic	pleiotropic	B-NP	JJ	O	19	NMOD	O
O	O	O	264	271	effects	effect	I-NP	NNS	O	17	OBJ	O
O	O	O	271	272	,	,	O	,	O	19	P	O
O	O	O	273	282	including	include	B-PP	VBG	O	19	NMOD	O
O	O	O	283	290	changes	change	B-NP	NNS	O	21	PMOD	O
O	O	O	291	293	in	in	B-PP	IN	O	22	NMOD	O
O	O	O	294	298	gene	gene	B-NP	NN	O	25	NMOD	O
O	O	O	299	309	expression	expression	I-NP	NN	O	23	PMOD	O
O	O	O	309	310	,	,	O	,	O	17	P	O
O	O	O	311	314	and	and	O	CC	O	17	VMOD	O
O	O	O	315	317	is	be	B-VP	VBZ	O	17	VMOD	O
O	O	O	318	325	thought	think	I-VP	VBN	O	28	VC	O
O	O	O	326	328	to	to	I-VP	TO	O	31	VMOD	O
O	O	O	329	338	represent	represent	I-VP	VB	O	29	VMOD	O
O	O	O	339	341	an	an	B-NP	DT	O	34	NMOD	O
O	O	O	342	347	early	early	I-NP	JJ	O	34	NMOD	O
O	O	O	348	353	event	event	I-NP	NN	O	31	OBJ	O
O	O	O	354	356	in	in	B-PP	IN	O	34	NMOD	O
O	O	O	357	370	atherogenesis	atherogenesis	B-NP	NN	O	35	PMOD	O
O	O	O	370	371	.	.	O	.	O	17	P	O

O	O	O	372	375	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	376	384	integral	integral	I-NP	JJ	B-protein	3	NMOD	B-protein
O	O	O	385	393	membrane	membrane	I-NP	NN	I-protein	6	SUB	I-protein
O	O	O	394	406	glycoprotein	glycoprotein	I-NP	NN	I-protein	5	NMOD	I-protein
T3	B-Protein	B-Protein	407	411	CD36	CD36	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	412	419	appears	appear	B-VP	VBZ	O	0	ROOT	O
O	O	O	420	422	to	to	I-VP	TO	O	8	VMOD	O
O	O	O	423	427	play	play	I-VP	VB	O	6	VMOD	O
O	O	O	428	429	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	430	443	physiological	physiological	I-NP	JJ	O	11	NMOD	O
O	O	O	444	448	role	role	I-NP	NN	O	8	OBJ	O
O	O	O	449	451	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	452	459	binding	binding	B-NP	NN	O	15	NMOD	O
O	O	O	460	463	and	and	I-NP	CC	O	15	NMOD	O
O	O	O	464	470	uptake	uptake	I-NP	NN	O	12	PMOD	O
O	O	O	471	473	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	474	476	Ox	Ox	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	477	480	LDL	LDL	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	O	481	483	by	by	B-PP	IN	O	15	NMOD	O
O	O	O	484	492	monocyte	monocyte	B-NP	NN	B-cell_type	22	NMOD	B-cell_type
O	O	O	492	493	-	-	O	HYPH	O	22	P	O
O	O	O	493	504	macrophages	macrophage	B-NP	NNS	B-cell_type	19	PMOD	B-cell_type
O	O	O	504	505	,	,	O	,	O	6	P	O
O	O	O	506	514	although	although	B-SBAR	IN	O	6	VMOD	O
O	O	O	515	518	the	the	B-NP	DT	O	27	NMOD	O
O	O	O	519	528	molecular	molecular	I-NP	JJ	O	27	NMOD	O
O	O	O	529	535	events	event	I-NP	NNS	O	35	SUB	O
O	O	O	536	546	associated	associate	B-VP	VBN	O	27	NMOD	O
O	O	O	547	551	with	with	B-PP	IN	O	28	VMOD	O
T4	B-Protein	B-Protein	552	556	CD36	CD36	B-NP	NN	B-protein	34	NMOD	B-protein
O	O	O	556	557	-	-	I-NP	HYPH	O	34	NMOD	O
O	O	O	557	559	Ox	Ox	I-NP	NN	B-protein	34	NMOD	B-protein
O	O	O	560	563	LDL	LDL	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	O	564	575	interaction	interaction	I-NP	NN	O	29	PMOD	O
O	O	O	576	579	are	be	B-VP	VBP	O	24	SBAR	O
O	O	O	580	587	unknown	unknown	B-ADJP	JJ	O	35	PRD	O
O	O	O	587	588	.	.	O	.	O	6	P	O

O	O	O	589	591	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	592	600	approach	approach	I-VP	VB	O	7	VMOD	O
O	O	O	601	605	this	this	B-NP	DT	O	4	NMOD	O
O	O	O	606	611	issue	issue	I-NP	NN	O	2	OBJ	O
O	O	O	611	612	,	,	O	,	O	7	P	O
O	O	O	613	615	we	we	B-NP	PRP	O	7	SUB	O
O	O	O	616	620	used	use	B-VP	VBD	O	0	ROOT	O
T5	B-Protein	B-Protein	621	625	CD36	CD36	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	626	637	transfected	transfecte	B-VP	VBN	O	7	OBJ	O
O	O	O	638	645	Chinese	Chinese	B-NP	JJ	B-cell_line	16	NMOD	B-cell_line
O	O	O	646	654	hampster	hampster	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	O	655	660	ovary	ovary	I-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	O	661	662	(	(	O	(	I-cell_line	16	NMOD	I-cell_line
O	O	O	662	665	CHO	CHO	B-NP	NN	I-cell_line	16	NMOD	I-cell_line
O	O	O	665	666	)	)	I-NP	)	I-cell_line	16	NMOD	I-cell_line
O	O	O	667	672	cells	cell	I-NP	NNS	I-cell_line	9	NMOD	I-cell_line
O	O	O	672	673	,	,	O	,	O	7	P	O
O	O	O	674	681	exposed	expose	B-VP	VBD	O	7	VMOD	O
O	O	O	682	686	them	them	B-NP	PRP	O	18	OBJ	O
O	O	O	687	689	to	to	B-PP	TO	O	18	VMOD	O
O	O	O	690	692	Ox	Ox	B-NP	NN	B-protein	22	NMOD	B-protein
O	O	O	693	696	LDL	LDL	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	O	696	697	,	,	O	,	O	7	P	O
O	O	O	698	701	and	and	O	CC	O	7	VMOD	O
O	O	O	702	712	determined	determine	B-NP	VBN	O	7	VMOD	O
O	O	O	713	720	changes	change	I-NP	NNS	O	25	OBJ	O
O	O	O	721	723	in	in	B-PP	IN	O	26	NMOD	O
O	O	O	724	727	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	728	736	activity	activity	I-NP	NN	O	27	PMOD	O
O	O	O	737	739	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	740	743	the	the	B-NP	DT	O	33	NMOD	O
T15	B-Entity	B-Entity	744	757	transcription	transcription	I-NP	NN	B-protein	33	NMOD	B-protein
T15	I-Entity	I-Entity	758	764	factor	factor	I-NP	NN	I-protein	36	NMOD	I-protein
T16	I-Entity	I-Entity	765	767	NF	NF	I-NP	NN	B-protein	36	NMOD	B-protein
T16	I-Entity	I-Entity	767	768	-	-	B-NP	HYPH	I-protein	36	NMOD	I-protein
T16	I-Entity	I-Entity	768	774	kappaB	kappaB	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	O	774	775	.	.	O	.	O	7	P	O

O	O	O	776	778	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	779	785	report	report	B-VP	VBP	O	0	ROOT	O
O	O	O	786	790	here	here	B-ADVP	RB	O	2	VMOD	O
O	O	O	791	795	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	796	798	Ox	Ox	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	799	802	LDL	LDL	I-NP	NN	I-protein	7	SUB	I-protein
O	O	O	803	811	enhanced	enhance	B-VP	VBD	O	4	SBAR	O
O	O	O	812	815	DNA	DNA	B-NP	NN	O	10	NMOD	O
O	O	O	816	823	binding	binding	I-NP	NN	O	10	NMOD	O
O	O	O	824	832	activity	activity	I-NP	NN	O	7	OBJ	O
O	O	O	833	835	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	836	843	nuclear	nuclear	B-NP	JJ	O	13	NMOD	O
O	O	O	844	852	extracts	extract	I-NP	NNS	O	11	PMOD	O
O	O	O	853	855	to	to	B-PP	TO	O	10	NMOD	O
O	O	O	856	858	an	an	B-NP	DT	O	19	NMOD	O
T17,T18	B-Entity,B-Entity	B-Entity,B-Entity	859	861	NF	NF	I-NP	NN	O	19	NMOD	O
T17,T18	I-Entity,I-Entity	I-Entity,I-Entity	861	862	-	-	B-NP	HYPH	O	19	NMOD	O
T17,T18	I-Entity,I-Entity	I-Entity,I-Entity	862	868	kappaB	kappaB	I-NP	NN	B-DNA	19	NMOD	B-DNA
T17	I-Entity	I-Entity	869	877	sequence	sequence	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	O	878	887	following	follow	B-PP	VBG	O	7	VMOD	O
O	O	O	888	898	activation	activation	B-NP	NN	O	20	PMOD	O
O	O	O	899	901	of	of	B-PP	IN	O	21	NMOD	O
T6	B-Protein	B-Protein	902	906	CD36	CD36	B-NP	NN	B-protein	22	PMOD	B-protein
O	O	O	906	907	-	-	O	HYPH	O	20	P	O
O	O	O	907	916	producing	produce	B-VP	VBG	O	20	PMOD	O
O	O	O	917	920	CHO	CHO	B-NP	NN	B-cell_line	27	NMOD	B-cell_line
O	O	O	921	926	cells	cell	I-NP	NNS	I-cell_line	25	OBJ	I-cell_line
O	O	O	927	931	with	with	B-PP	IN	O	27	NMOD	O
O	O	O	932	935	the	the	B-NP	DT	O	31	NMOD	O
O	O	O	936	951	proinflammatory	proinflammatory	I-NP	JJ	B-protein	31	NMOD	B-protein
O	O	O	952	960	cytokine	cytokine	I-NP	NN	I-protein	36	NMOD	I-protein
T7	B-Protein	B-Protein	961	966	tumor	tumor	I-NP	NN	B-protein	36	NMOD	B-protein
T7	I-Protein	I-Protein	967	975	necrosis	necrosis	I-NP	NN	I-protein	36	NMOD	I-protein
T7	I-Protein	I-Protein	976	982	factor	factor	I-NP	NN	I-protein	36	NMOD	I-protein
T7	I-Protein	I-Protein	982	983	-	-	O	HYPH	I-protein	36	P	I-protein
T7	I-Protein	I-Protein	983	988	alpha	alpha	B-NP	SYM	I-protein	28	PMOD	I-protein
O	O	O	989	990	(	(	O	(	O	41	DEP	O
T8	B-Protein	B-Protein	990	993	TNF	TNF	B-NP	NN	B-protein	40	NMOD	B-protein
T8	I-Protein	I-Protein	993	994	-	-	O	HYPH	I-protein	40	P	I-protein
T8	I-Protein	I-Protein	994	999	alpha	alpha	B-NP	SYM	I-protein	41	DEP	I-protein
O	O	O	999	1000	)	)	O	)	O	36	NMOD	O
O	O	O	1000	1001	.	.	O	.	O	2	P	O

O	O	O	1002	1006	This	This	B-NP	DT	O	5	NMOD	O
O	O	O	1007	1015	enhanced	enhance	I-NP	VBN	O	5	NMOD	O
O	O	O	1016	1019	DNA	DNA	I-NP	NN	O	5	NMOD	O
O	O	O	1020	1027	binding	binding	I-NP	NN	O	5	NMOD	O
O	O	O	1028	1036	activity	activity	I-NP	NN	O	6	SUB	O
O	O	O	1037	1040	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1041	1050	inhibited	inhibit	I-VP	VBN	O	6	VC	O
O	O	O	1051	1053	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	1054	1066	coincubation	coincubation	B-NP	NN	O	8	PMOD	O
O	O	O	1067	1069	of	of	B-PP	IN	O	9	NMOD	O
T9	B-Protein	B-Protein	1070	1074	CD36	CD36	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	1075	1086	transfected	transfecte	B-VP	VBN	O	13	NMOD	O
O	O	O	1087	1092	cells	cell	B-NP	NNS	O	10	PMOD	O
O	O	O	1093	1097	with	with	B-PP	IN	O	9	NMOD	O
O	O	O	1098	1101	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	1102	1107	human	human	I-NP	JJ	B-protein	17	NMOD	B-protein
T10	B-Protein	B-Protein	1108	1112	CD36	CD36	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	1112	1113	-	-	B-NP	HYPH	O	21	NMOD	O
O	O	O	1113	1121	specific	specific	I-NP	JJ	O	21	NMOD	O
O	O	O	1122	1130	antibody	antibody	I-NP	NN	O	21	NMOD	O
O	O	O	1131	1135	OKM5	OKM5	I-NP	NN	B-protein	14	PMOD	B-protein
O	O	O	1135	1136	.	.	O	.	O	6	P	O

O	O	O	1137	1139	We	We	B-NP	PRP	O	3	SUB	O
O	O	O	1140	1144	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	O	1145	1155	determined	determine	B-VP	VBD	O	0	ROOT	O
O	O	O	1156	1160	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1161	1171	activation	activation	B-NP	NN	O	13	SUB	O
O	O	O	1172	1174	of	of	B-PP	IN	O	5	NMOD	O
T19	B-Entity	B-Entity	1175	1177	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T19	I-Entity	I-Entity	1177	1178	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T19	I-Entity	I-Entity	1178	1184	kappaB	kappaB	I-NP	NN	I-protein	12	NMOD	I-protein
T20	I-Entity	I-Entity	1185	1188	DNA	DNA	I-NP	NN	O	12	NMOD	O
O	O	O	1189	1196	binding	binding	I-NP	NN	O	12	NMOD	O
O	O	O	1197	1205	activity	activity	I-NP	NN	O	6	PMOD	O
O	O	O	1206	1214	required	require	B-VP	VBD	O	4	SBAR	O
O	O	O	1215	1217	an	an	B-NP	DT	O	20	NMOD	O
O	O	O	1218	1224	intact	intact	I-NP	JJ	O	20	NMOD	O
T21,T22	B-Entity,B-Entity	B-Entity,B-Entity	1225	1233	carboxyl	carboxyl	I-NP	NN	B-protein	20	NMOD	B-protein
T21,T22	I-Entity,I-Entity	I-Entity,I-Entity	1233	1234	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T21,T22	I-Entity,I-Entity	I-Entity,I-Entity	1234	1242	terminal	terminal	I-NP	JJ	I-protein	20	NMOD	I-protein
T21,T22	I-Entity,I-Entity	I-Entity,I-Entity	1243	1254	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	20	NMOD	I-protein
T21,T22	I-Entity,I-Entity	I-Entity,I-Entity	1255	1262	segment	segment	I-NP	NN	I-protein	13	OBJ	I-protein
T21	I-Entity	I-Entity	1263	1265	on	on	B-PP	IN	O	20	NMOD	O
T11,T21	B-Protein,I-Entity	B-Protein,I-Entity	1266	1270	CD36	CD36	B-NP	NN	B-protein	21	PMOD	B-protein
O	O	O	1270	1271	.	.	O	.	O	3	P	O

O	O	O	1272	1275	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1276	1283	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1284	1291	support	support	B-VP	VBP	O	0	ROOT	O
O	O	O	1292	1295	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1296	1300	idea	idea	I-NP	NN	O	3	OBJ	O
O	O	O	1301	1305	that	that	B-SBAR	IN	O	5	NMOD	O
O	O	O	1306	1311	human	human	B-NP	JJ	B-protein	8	NMOD	B-protein
T12	B-Protein	B-Protein	1312	1316	CD36	CD36	I-NP	NN	I-protein	9	SUB	I-protein
O	O	O	1317	1325	mediates	mediate	B-VP	VBZ	O	6	SBAR	O
O	O	O	1326	1332	signal	signal	B-NP	NN	O	12	NMOD	O
O	O	O	1333	1345	transduction	transduction	I-NP	NN	O	12	NMOD	O
O	O	O	1346	1352	events	event	I-NP	NNS	O	9	OBJ	O
O	O	O	1353	1355	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	1356	1364	response	response	B-NP	NN	O	13	PMOD	O
O	O	O	1365	1367	to	to	B-PP	TO	O	14	NMOD	O
O	O	O	1368	1370	Ox	Ox	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	O	1371	1374	LDL	LDL	I-NP	NN	I-protein	15	PMOD	I-protein
O	O	O	1374	1375	.	.	O	.	O	3	P	O
